Evgen Pharma Plc (EVG)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Evgen Pharma Plc (EVG) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013382
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:35
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:イギリス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Evgen Pharma Plc (Evgen Pharma), formerly Evgen Pharma Ltd is a drug discovery company that develops medicines to treat cancer and neurological diseases. The company uses sulforadex technology that synthesizes and concurrently stabilizes the naturally occurring compound such as sulforaphane. It carries out preclinical work in multiple sclerosis and has a clinical interest in prostate cancer. Evgen Pharma also undertakes clinical plans in oncology in patients with ER+ metastatic breast cancer. The company’s SFX-01 is a patented composition of the synthetic sulforaphane and alpha-cyclodextrin and has completed phase I clinical trials, and others. Evgen Pharma is headquartered in Wilmslow, the UK.

Evgen Pharma Plc (EVG) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Evgen Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deal Details 10
Venture Financing 10
Evgen Pharma Raises USD3.1 Million Financing 10
Evgen Raises US$0.72 Million In Series B Financing 11
Evgen Secures Series A Financing 12
Licensing Agreements 13
Evgen Pharma Exercises Option for Licensing Agreement with CSIC and University of Seville 13
Evgen Exercises Option for Licensing Agreement with PharmAgra and Lalilab for Sulforade 14
Equity Offering 15
Evgen Pharma Raises USD11 Million in IPO 15
Evgen Pharma Plc – Key Competitors 16
Evgen Pharma Plc – Key Employees 17
Evgen Pharma Plc – Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 19
Financial Announcements 19
Jun 13, 2017: Evgen Pharma Announces Final Results for the year ended 31 March 2017 19
Dec 05, 2016: Evgen Pharma: Interim results for the six months ended 30 September 2016 20
May 31, 2016: Evgen Pharma Announces Final Results for the year ended 31 March 2016 21
Corporate Communications 25
Apr 03, 2017: Evgen Pharma Announces Directorate Change 25
Jan 17, 2017: Evgen Pharma: Appointment of CFO and Head of Clinical Operations 26
Jan 04, 2016: Evgen Pharma Appoints Chief Medical Officer 27
Clinical Trials 28
Sep 15, 2016: Update re SFX-01 Data at ECTRIMS 2016 28
Sep 08, 2016: Evgen Pharma Announces Presentation of SFX-01 Data at ECTRIMS 2016 29
Aug 24, 2016: Evgen Pharma Announces Orphan Designation in the USA in Subarachnoid Haemorrhage 30
Aug 17, 2016: Evgen Pharma: Clinical Trial Approval for Phase II Study in Breast Cancer 31
May 03, 2016: Evgen Pharma: First Patient Dosed in Phase II Clinical Trial in SAH 33
Mar 02, 2016: Approval of Phase II Clinical Trial in SAH 34
Appendix 35
Methodology 35
About GlobalData 35
Contact Us 35
Disclaimer 35

List of Tables
Evgen Pharma Plc, Pharmaceuticals & Healthcare, Key Facts, 2017 2
Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Evgen Pharma Plc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Evgen Pharma Plc, Deals By Therapy Area, 2011 to YTD 2017 8
Evgen Pharma Plc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Evgen Pharma Raises USD3.1 Million Financing 10
Evgen Raises US$0.72 Million In Series B Financing 11
Evgen Secures Series A Financing 12
Evgen Pharma Exercises Option for Licensing Agreement with CSIC and University of Seville 13
Evgen Exercises Option for Licensing Agreement with PharmAgra and Lalilab for Sulforade 14
Evgen Pharma Raises USD11 Million in IPO 15
Evgen Pharma Plc, Key Competitors 16
Evgen Pharma Plc, Key Employees 17
Evgen Pharma Plc, Other Locations 18

★海外企業調査レポート[Evgen Pharma Plc (EVG)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Solar Frontier KK:電力:M&Aディール及び事業提携情報
    Summary Solar Frontier KK (Solar Frontier), a subsidiary of Showa Shell Sekiyu K.K. is a renewable energy company that offers solar energy equipment. The company develops and manufacturers copper, indium and selenium thin film photovoltaic modules. It develops power plant projects and manages power …
  • Abu Dhabi National Oil Co:企業の戦略的SWOT分析
    Abu Dhabi National Oil Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Veracyte Inc (VCYT):企業の財務・戦略的SWOT分析
    Summary Veracyte Inc (Veracyte) is a molecular diagnostics company that uses genomic technology to resolve diagnostic ambiguity. The company’s pipeline products include Afirma thyroid FNA analysis for the diagnosis of thyroid cancer based on its proprietary afirma gene expression classifier. It also …
  • PolyOne Corp (POL):企業の財務・戦略的SWOT分析
    PolyOne Corp (POL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Aggreko Plc (AGK):企業の戦略的SWOT分析
    Aggreko Plc (AGK) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and serv …
  • LIXIL Group Corporation:企業の戦略・SWOT・財務情報
    LIXIL Group Corporation - Strategy, SWOT and Corporate Finance Report Summary LIXIL Group Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Singapore Power Ltd:企業の戦略的SWOT分析
    Singapore Power Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Kaiser Permanente
    Kaiser Permanente - Strategy, SWOT and Corporate Finance Report Summary Kaiser Permanente - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • 3D Signatures Inc (DXD):医療機器:M&Aディール及び事業提携情報
    Summary 3D Signatures Inc (3D Signatures) is a developer of diagnostic and prognostic products for cancers and neurological disorders. The company's pipeline products include 3D Telo-PC a tool that is used to treat prostate cancer. It also provides 3D Telo-RS a diagnostic and prognostic tool used fo …
  • Pattern Energy Group Inc.:企業のM&A・事業提携・投資動向
    Pattern Energy Group Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Pattern Energy Group Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisi …
  • National Fuel Gas Company:企業の戦略・SWOT・財務情報
    National Fuel Gas Company - Strategy, SWOT and Corporate Finance Report Summary National Fuel Gas Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Senseonics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Senseonics Inc (Senseonics), a subsidiary of Senseonics Holdings Inc, is a medical device company that designs, develops and commercializes of glucose monitoring products. Its products, Eversense and Eversense XL, are implantable continuous glucose monitoring (CGM) systems that help people w …
  • MAN Energy Solutions SE:企業の戦略的SWOT分析
    MAN Energy Solutions SE - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products an …
  • The Advisory Board Company (ABCO):企業の財務・戦略的SWOT分析
    The Advisory Board Company (ABCO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and we …
  • Safeguard Scientifics Inc (SFE):企業の財務・戦略的SWOT分析
    Summary Safeguard Scientifics Inc (Safeguard Scientifics), formerly Lancaster Corp, is a provider of finance, healthcare and digital media solutions. The company offers business intelligence and analytics for institutional/capital markets, insurance technology, regulatory and compliance technology a …
  • SKC Co., Ltd. (011790):企業の財務・戦略的SWOT分析
    SKC Co., Ltd. (011790) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …
  • Yapi Merkezi Holding Inc.
    Yapi Merkezi Holding Inc. - Strategy, SWOT and Corporate Finance Report Summary Yapi Merkezi Holding Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Noxilizer Inc-医療機器分野:企業M&A・提携分析
    Summary Noxilizer Inc (Noxilizer) is a medical device company that manufactures sterilization equipment. The company’s products include industrial nitrogen dioxide sterilizer and biodecontamination systems. Its services comprise installation, contract sterilization services, and maintenance services …
  • Anavex Life Sciences Corp (AVXL):製薬・医療:M&Aディール及び事業提携情報
    Summary Anavex Life Sciences Corp (Anavex) is a clinical-stage biopharmaceutical company that focuses on developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases, other central nervous system (CNS) diseases, pain and various types of cancer. The c …
  • Aldevron LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Aldevron LLC (Aldevron) is a provider of contract plasmid DNA manufacturing, protein production and antibody discovery services. The company develops and manufactures plasmid deoxyribonucleic acid (Plasmid DNA), proteins and antibodies for research, preclinical and clinical applications serv …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆